Reliability of routine disc susceptibility testing by the British Society for Antimicrobial Chemotherapy (BSAC) method

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 5, 2004, Pages 729-738

  Potz, Nicola A C ^a   Mushtaq, S ^a   Johnson, A P ^a   Henwood, C J ^a   Walker, R A ^a,b   Varey, E ^a,c   Warner, M ^a   James, D ^a   Livermore, D M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Wells Healthcare Communications Ltd   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Minimum inhibitory concentration; Standardized method; Zone diameter

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; MEROPENEM; METICILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL LABORATORY; DILUTION; ENTEROBACTERIACEAE; ENTEROCOCCUS; MEDICAL SOCIETY; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PROCESS MONITORING; PSEUDOMONADACEAE; RELIABILITY; STANDARDIZATION; STAPHYLOCOCCUS;

BACTERIA; BACTERIAL INFECTIONS; DATA COLLECTION; GREAT BRITAIN; HUMANS; LABORATORIES; MICROBIAL SENSITIVITY TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 2442704155     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh212     Document Type: Article

References (16)

1. Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
2. Andrews, J. M. for the BSAC Working Party on Susceptibility Testing. (2001). BSAC standardized disc susceptibility testing method. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 43-57.
3. Andrews, J. (2004). BSAC Disc Diffusion Method for Antimicrobial Susceptibility testing. Version 3 [Online.] http://www.bsac.org.uk (18 February 2004, date last accessed).
4. Andrews, J. M. (2001). The development of the BSAC standardized method of disc diffusion testing. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 29-42.
5. Henwood, C. J., Livermore, D. M., James, D. et al. (2001). Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test. Journal of Antimicrobial Chemotherapy 47, 789-99.
6. Johnson, A. P., Henwood, C., Mushtaq, S. et al. (2003). Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents. Journal of Hospital Infection 54, 179-87.
7. Livermore, D. M., Mushtaq, S., James, D. et al. (2003). In-vitro activity of piperacillin-tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles. International Journal of Antimicrobial Agents 22, 14-27.
8. Dutka-Malen, S., Evers, S. & Courvalin, P. (1995). Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology 33, 24-7.
9. Robredo, B., Singh, K. V., Torres, C. et al. (1999). Identification to the species level by PCR of Enterococcus hirae and Enterococcus durans. In Programs and Abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 1576, p. 228. American Society for Microbiology, Washington, DC, USA.
10. Andrews, J. M. (2001). Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 5-16.
11. Bignardi, G. E., Woodford, N., Chapman, A. et al. (1996). Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance. Journal of Antimicrobial Chemotherapy 37, 53-63.
12. Livermore, D. M. (2002). Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clinical Infectious Diseases 34, 634-40.
13. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
14. Livermore, D. M., Winstanley, T. G. & Shannon, K. P. (2001). Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 87-102.
15. Andrews, J. M., Boswell, F. J. & Wise, R. (2000). Establishing MIC breakpoints for coagulase-negative staphylococci to oxacillin. Journal of Antimicrobial Chemotherapy 45, 259-61.
16. Kenny, M. T., Mayer, G. D., Dulworth, J. K. et al. (1992). Evaluation of the teicoplanin broth microdilution and disc diffusion susceptibility tests and recommended interpretive criteria. Diagnostic Microbiology and Infectious Disease 15, 609-12.